bluebird bio (NASDAQ:BLUE) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the company. Wells Fargo & Company cut their price target on bluebird bio from […]
StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the company. Wells Fargo & Company cut their price target on bluebird bio from […]
